ANXA1 and Keratoconjunctivitis sicca: AnxA1 could be used therapeutically to treat the multiple inflammatory diseases of the ocular surface especially dry eye and ocular allergy as well as to prevent these diseases or to maintain ocular surface homeostasis in health.